The Board and staff of RESULTS Canada are pleased to announce the appointment of Chris Dendys as executive director. Chris has had a long affiliation with RESULTS, having served with the organization from 2006 to 2011 and returning in recent months to serve as part-time and interim ED.
Washington, D.C. (Jan. 22) - The ACTION Leadership Group is pleased to announce that Health Promotion Tanzania (HDT), a non-profit organization based in Dar es Salaam, has formally joined the partnership as lead in-country advocacy partner in Tanzania.
Civil society warns talk is not enough
Moscow, Russia (Nov. 17, 2017) – Civil society participants highlighted the importance of building on new political resolve to end tuberculosis (TB) at the first-ever WHO Global Ministerial Conference on TB.
Washington, D.C. (Nov. 7, 2017)—Malnutrition, a condition caused by lack of food or insufficient amounts of the nutrients the body needs, is a reality for hundreds of millions of people globally and a growing threat to meeting the United Nations Sustainable Development Goals, according to the 2017 Global Nutrition Report (GNR).
Washington, D.C. (Oct. 30, 2017) – New data released today by the World Health Organization (WHO) shows that progress toward ending tuberculosis (TB), already the world’s leading infectious killer, is stagnant. According to the WHO report, 10.4 million people fell ill with TB in 2016—600,000 cases being drug-resistant—and that 1.7 million people died from the disease. Last year, two out of every five people with TB were undiagnosed or unreported, making the already inadequate, underfunded global response to this airborne disease even starker.
Berlin, Germany (13 October) – At the Berlin “Call to Action” conference on anti-microbial resistance (AMR), the ACTION global health advocacy partnership joined governments, civil society, the private sector, and other stakeholders to make the following commitment.
Washington, D.C. (Sept. 14, 2017) – While at least 24 developing countries are at risk of losing funding from multiple multilateral institutions for key health programs simultaneously in the next five years, government and key stakeholders either do not believe or are not aware that these transitions are likely to take place. Additionally, despite their individual transition policies, there is little evidence of serious efforts by institutions like Gavi, the Vaccine Alliance; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the Global Polio Eradication Initiative (GPEI); or the World Bank, to tackle the multiplier effect of simultaneous transitions in a coordinated way.
ACTION global health advocacy partnership applauds G20 leaders’ call for a new platform to incentivize the research and development needed to combat priority pathogens, including tuberculosis (TB). As the world’s leading infectious disease killer and the only airborne drug-resistant infection, TB is the nexus of the growing crisis of antimicrobial resistance (AMR), when organisms no longer respond to available drugs.